1
Trimebutine Maleate Combined With Rabeprazole in Patients With Grade A or B Reflux Esophagitis Whose Symptoms Refractory to Rabeprazole
Condition(s):Refractory Reflux EsophagitisLast Updated:February 1, 2023Withdrawn
Hide Studies Not Open or Pending
Condition(s):Refractory Reflux EsophagitisLast Updated:February 1, 2023Withdrawn
Condition(s):Adverse Drug Reaction; Cinepazide; StrokeLast Updated:July 27, 2022Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.